Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers

NCT02409121

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +15 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Clinical and Pathophysiological Investigations Into Erdheim Chester Disease

NCT01417520

Conditions: Albinism, Albinism, Oculocutaneous, Amino Acid Metabolism, Inborn Errors, +50 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT01699152

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: GRU Augusta, Georgia, United States

DFCI Boston, Massachusetts, United States

OSU Columbus, Ohio, United States

SCRI Nashville, Tennessee, United States

View Trial Details

Completed

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

NCT03376958

Conditions: Diffuse Large B Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Oncology Department of The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Completed

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

NCT02809573

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Completed

FLT PET: A Pilot Study in Lymphoma Patients

NCT04028804

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations: The Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

NCT00162032

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Kawasaki Disease, +7 more
Locations: Local Institution Anchorage, Alaska, United States

Local Institution Little Rock, Arkansas, United States

Local Institution Los Angeles, California, United States

Local Institution Orange, California, United States

View all 50 locations

View Trial Details

Completed

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma

NCT00198133

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305

Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

NCT02187783

Conditions: Adenoma, Adnexal Diseases, Breast Diseases, +31 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Alaska Clinical Research Anchorage, Alaska, United States

Arizona Oncology Associates Dept. Of Onc. Phoenix, Arizona, United States

University of Arkansas/ Arkansas Cancer Research Center UA Medical Sciences Little Rock, Arkansas, United States

View all 61 locations

View Trial Details